Literature DB >> 15890237

Cytotoxicity determination without photochemical artifacts.

Michael Heuser1, Marijana Kopun, Werner Rittgen, Christof Granzow.   

Abstract

A study was performed to improve cytotoxicity determinations by eliminating flavin-mediated photosensitization from tests with KB cells, NCI-H69 cells, P-glycoprotein expressing KBC5-8 cells, MRP1-expressing H69AR cells, and A240286S human lung adenocarcinoma cells. Growth inhibition by cis-platin, doxorubicin, etoposide, gemcitabine, taxol, vincristine, vinblastine, and vinorelbine was determined under flavin-protecting conditions using flavin-free culture media with fetal bovine serum as the only source of flavins. As compared to conventional tests, the IC50 values determined under flavin-protecting conditions reflected increased apparent drug cytotoxicities, and were flawlessly reproducible. Flavin-mediated photosensitization should, therefore, be strictly eliminated from in vitro experiments involving cytotoxic and other drugs.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15890237     DOI: 10.1016/j.canlet.2004.10.031

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  Chemoresponse Assay in Head and Neck Cancer Patients: A Three-Year Follow Up.

Authors:  Basem T Jamal; Gregory A Grillone; Scharukh Jalisi
Journal:  J Clin Diagn Res       Date:  2017-05-01

2.  Assay-based response evaluation in head and neck oncology: requirements for better decision making.

Authors:  Andreas Dietz; Andreas Boehm; Iris-Susanne Horn; Pierre Kruber; Ingo Bechmann; Wojciech Golusinski; Dietger Niederwieser; Ralph Dollner; Torsten W Remmerbach; Christian Wittekind; Stephan Dietzsch; Guido Hildebrandt; Gunnar Wichmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-01-06       Impact factor: 2.503

3.  Cytokine Profiles of Head and Neck Squamous Cell Carcinoma Undergoing Dual Immunotherapy With Cetuximab and Pembrolizumab Identify Interferon Gamma-Induced Protein 10 as Novel Biomarker.

Authors:  Michael Berszin; Ioannis Michaelides; Julia Siemert; Louisa Röhl; Jana Wellhausen; Theresa Wald; Christopher Bohr; Julian Künzel; Tanja Gradistanac; Andreas Dietz; Veit Zebralla; Markus Pirlich; Susanne Wiegand; Gunnar Wichmann
Journal:  Front Oncol       Date:  2022-02-28       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.